About Northwestern Medicine Developmental Therapeutics Institute
"Northwestern Medicine is proud to have five hospitals ranked among “America’s Best” by U.S. News & World Report, 2021-22. Anchored by Northwestern Memorial Hospital, the #1 hospital in Illinois and a top 10 hospital in the nation, we’re leading the quest for better care and better treatments in the Chicagoland area. With more than 200 locations across Chicagoland, better care and better treatments are never far from home. To learn more, visit our website."
Clinical Trials at Northwestern Medicine Developmental Therapeutics Institute
During the past decade, Northwestern Medicine Developmental Therapeutics Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Medicine Developmental Therapeutics Institute"
#1 collaborator was "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Northwestern Medicine Developmental Therapeutics Institute
According to Clinical.Site data, the most researched conditions in "Northwestern Medicine Developmental Therapeutics Institute" are
"Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Tumors With CDK4/6 Pathway Activation" (1 trials). Many other conditions were trialed in "Northwestern Medicine Developmental Therapeutics Institute" in a lesser frequency.
Clinical Trials Intervention Types at Northwestern Medicine Developmental Therapeutics Institute
Most popular intervention types in "Northwestern Medicine Developmental Therapeutics Institute" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Cytarabine" (1 trials), "Daunorubicin" (1 trials), "Decitabine" (1 trials), "FLAG (fludarabine, cytarabine and G-CSF)" (1 trials) and "HIDAC (high dose cytarabine)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Northwestern Medicine Developmental Therapeutics Institute
The vast majority of trials in "Northwestern Medicine Developmental Therapeutics Institute" are
3 trials for "All" genders.
Clinical Trials Status at Northwestern Medicine Developmental Therapeutics Institute
Currently, there are NaN active trials in "Northwestern Medicine Developmental Therapeutics Institute".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Northwestern Medicine Developmental Therapeutics Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Northwestern Medicine Developmental Therapeutics Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".